Orthostatic Hypotension and Therapy with an Ace Inhibitor in Hypertensive Patients

1. Fatima S. et al., A review on importance of ACE inhibitors in clinical practice. Med. Res. Chron., 2014, 1 (1), 102-109.Search in Google Scholar

2. Mancia G. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul; 31(7): 1281-357.10.1097/01.hjh.0000431740.32696.cc23817082Search in Google Scholar

3. Wiseman LR, McTavish D. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs 1994, 48:71-90.10.2165/00003495-199448010-000077525196Search in Google Scholar

4. Freeman R et al. Neurogenic Orthostatic Hypotension. N Engl J Med. 2008; 358:615-62410.1056/NEJMcp07418918256396Search in Google Scholar

5. Low P et al. Prevalence of orthostatic hypotension. Clin Auton Res 2007 18[Suppl 1]:8-13.10.1007/s10286-007-1001-318368301Search in Google Scholar

6. Gupta V, Lipsitz LA Orthostatic Hypotension in the Elderly: Diagnosis and Treatment. Am J Med 2007; 120: 841-847.10.1016/j.amjmed.2007.02.02317904451Search in Google Scholar

7. Zia A, Kamaruzzaman SB, Tan MP. Blood pressure lowering therapy in older people: Does it really cause postural hypotension or falls? Postgraduate medicine. 2015; 127(2):186-93.10.1080/00325481.2015.99650525622817Search in Google Scholar

8. Shibao C et al. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clinic Hypertension. 2013; 15(3): 147-53.10.1111/jch.12062803389323458585Search in Google Scholar

9. Lahrmann H et al. Orthostatic hypotension. In European Handbook of Neurological Managemen. 2011; Volume 1, 2nd Edition. 469-75.10.1002/9781444328394.ch33Search in Google Scholar

10. Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension. 1998;32:298-304.10.1161/01.HYP.32.2.2989719058Search in Google Scholar

11. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19(6 Pt 1):508-519.10.1161/01.HYP.19.6.5081592445Open DOISearch in Google Scholar

12. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011; 21: 69-72.10.1007/s10286-011-0119-521431947Search in Google Scholar

13. Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melander O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle- aged individuals (The Malmo¨ Preventive Project). European Heart Journal.2010; 31: 85-91.10.1093/eurheartj/ehp329280091919696189Open DOISearch in Google Scholar

14. Eigenbrodt M et al. Orthostatic Hypotension as a Risk Factor for Stroke The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1996. Stroke. 2000;31:2307-2313.10.1161/01.STR.31.10.2307Search in Google Scholar

15. Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing. 2010;39:51-56.10.1093/ageing/afp19219897539Search in Google Scholar

16. Canney M et al. Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. PLoS ONE 11(1): e0146156. doi:10.1371.Search in Google Scholar

17. Montastruc JL, Laborie I, Bagheri H, Senard JM. Drug- Induced Orthostatic Hypotension: A Five-Year Experience in a Regional Pharmacovigilance Centre in France Clin Drug Invest. 1997; 14(1): 61-65.10.2165/00044011-199714010-00008Open DOISearch in Google Scholar

18. Furlan et al. Chronic Orthostatic Intolerance A Disorder With Discordant Cardiac and Vascular Sympathetic Control. Circulation. 1998;98:2154-2159.10.1161/01.CIR.98.20.2154Open DOISearch in Google Scholar

19. De Ponti F, Marelli C, D’Angelo L, Caravaggi M, Bianco L, Lecchini S, Frigo GM, Crema A. Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers. Eur J Clin Pharmacol. 1991;40(2):149-53.10.1007/BF002800691648489Search in Google Scholar

20. Li X, Liu C, Wu M, Zhang H, Sun Y, Cheng L, Chen H, Liu C, Yang L, Zhang Q, Cao Y, Gu J, Ding Y. Pharmacokinetics, Pharmacodynamics, and Tolerability of Single and Multiple Doses of Trandolapril, an Effective Angiotensin-Converting Enzyme Inhibitor, in Healthy Chinese Subjects. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):373-84.10.1007/s13318-015-0277-225864194Open DOISearch in Google Scholar